IL6 and chronic kidney disease: Numerous research efforts align with our results, and prior studies have demonstrated MAPK, NF-κB, Interleukin-6 (IL-6) and cytokine-receptor pathways are key in the pathogenesis of CKD (Bruggeman, 2007).